Global Antibiotic Use
Study highlights high antimicrobial resistance rates, limited data in African countries

The University of Minnesota’s CIDRAP featured a major new study by One Health Trust researchers and collaborators.  This is the largest retrospective analysis to date on antimicrobial susceptibility data from African countries. The study, published in PLOS Medicine, reveals high levels (up to 70% in some countries) of antimicrobial resistance (AMR) in critical pathogens such as […]

Read moreRead more Read More


  • Filter by:

  • Reset filters

  • GARP Nepal in-person workshop on antimicrobial resistance and vaccines

    The One Health Trust (OHT) and the Nepal Public Health Foundation (NPHF), organized the Global Antibiotic Resistance Partnership (GARP) Nepal in-person workshop on antimicrobial resistance and vaccines on January 11, 2024. Experts from several public health institutions joined the discussion on using vaccines in the fight against antimicrobial resistance in the country, including NPHF, the […]

    Read moreRead more Read More Shape
  • Are laws for stray dogs good only on paper?

    Out in The Week, an article features OHT’s Dr. Ramanan Laxminarayan’s commentary on the growing stray dog menace in India, primarily due to the lack of effective sterilization programs in the country. As per the data released by the Indian government’s Department of Animal Husbandry and Dairying, the number of dog bites reported in the country has surged […]

    Read moreRead more Read More Shape
  • India’s Fight Against Antimicrobial Resistance

    An article published in Nature sheds light on what India is doing to mitigate the spread of antimicrobial resistance — which has emerged as a major public health threat due to the country’s poorly regulated pharmaceutical industry and a public–private divide in healthcare that has not only contributed to the excessive use of antibiotics but […]

    Read moreRead more Read More Shape
  • India detects JN.1 Covid variant in Kerala as case numbers rise

    Out in The National News, an article reveals that India detected its first case of the JN.1 coronavirus sub-variant amid a sharp surge in Covid-19 cases and hospitalizations, thus prompting health authorities to ask states to increase precautionary measures against the spread of infections. OHT’s Dr. Ramanan Laxminarayan comments, “COVID is with us permanently and […]

    Read moreRead more Read More Shape
  • Experts emphasize vaccines to prevent antimicrobial resistance

    Out in the Dhaka Mail, an article covers the “Antimicrobial Resistance and Vaccines Workshop” organized by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and the Global Antibiotic Resistance Partnership (GARP). Find the article here.

    Read moreRead more Read More Shape
  • Workshop on Importance of Vaccines to Reduce Antimicrobial Resistance

    An article published in the Bangla Tribune covers the “Antimicrobial Resistance and Vaccines Workshop” organized by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and the Global Antibiotic Resistance Partnership (GARP). Find the article here.

    Read moreRead more Read More Shape
  • Value of Vaccines to Mitigate Antimicrobial Resistance in Bangladesh Explored

    An article published in the Daily Sun covers the “Antimicrobial Resistance and Vaccines Workshop” organized by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and the Global Antibiotic Resistance Partnership (GARP), an initiative led by OHT to promote actionable policies to control the spread of drug resistance in Dhaka, Bangladesh. The workshop, funded by the […]

    Read moreRead more Read More Shape
  • Vaccines Can Help Mitigate Antimicrobial Resistance

    An article published in The Financial Express covers the “Antimicrobial Resistance and Vaccines Workshop – Bangladesh” held in Dhaka and organized by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and the Global Antibiotic Resistance Partnership (GARP), an initiative led by OHT to promote actionable policies to control the emergence and spread of drug […]

    Read moreRead more Read More Shape
  • Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.

    An article published in The New York Times covers the exciting story about the groundbreaking oral treatment for gonorrhea, Zoliflodacin, acing its phase 3 clinical trials. The nonprofit, GARDP, developed the antibiotic in collaboration with an American pharmaceutical company called Innoviva Specialty Therapeutics. The nonprofit sponsored the Phase 3 trial of the drug. In exchange, it holds […]

    Read moreRead more Read More Shape